Guy's and St Thomas' NHS Foundation Trust

gstt.nhs.uk

Total trials

286

Active

60

Phase 3

16

Total enrollment

106,593

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 9 of 9 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Supported rescue pack1
Sodium bicarbonate1
standard care1
Usual care1
Aspirin 75 mg daily1
Clopidogrel 75 mg daily1
Clopidgrel 75 mg daily1
Aspirin 75 mg daily + Clopidgrel 75 mg daily1
Photosensitizer formulation only1

Next readouts

  • 2024-07-30
  • 2025-08-31
  • 2026-07-01
  • 2027-12
  • 2027-12-31

Top conditions

  • Heart Failure12
  • COPD8
  • Prostate Cancer7
  • Cataract7
  • Critical Illness6
  • Chronic Obstructive Pulmonary Disease6
  • Asthma6
  • Covid195

Frequently asked questions about Guy's and St Thomas' NHS Foundation Trust

How many clinical trials does Guy's and St Thomas' NHS Foundation Trust have on ClinicalTrials.gov?
Guy's and St Thomas' NHS Foundation Trust is listed as the lead sponsor on 286 clinical trials in ClinicalTrials.gov, 60 of which are currently active (recruiting, enrolling, or ongoing).
How many of Guy's and St Thomas' NHS Foundation Trust's trials are in Phase 3?
16 of Guy's and St Thomas' NHS Foundation Trust's trials are in Phase 3, spread across 9 active drug programs.
What therapeutic areas does Guy's and St Thomas' NHS Foundation Trust focus on?
Guy's and St Thomas' NHS Foundation Trust's most-studied conditions on ClinicalTrials.gov are Heart Failure, COPD, Prostate Cancer, Cataract, Critical Illness.
When are Guy's and St Thomas' NHS Foundation Trust's next clinical trial readouts?
Guy's and St Thomas' NHS Foundation Trust has 5 upcoming primary-completion readouts tracked here; the soonest is “Urine Alkalinisation in COVID-19”, expected around 2024-07-30.